Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T09:54:44.019Z Has data issue: false hasContentIssue false
  • English
  • Français

Unilateral vocal cord paralysis in squamous cell lung cancer treated with stereotactic body radiation therapy

Published online by Cambridge University Press:  09 September 2016

Yusef A. Syed ,
Sung Jun Ma  and
Jorge Gomez
Yusef A. Syed
Affiliation:
University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Sung Jun Ma
Affiliation:
University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Jorge Gomez*
Affiliation:
Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
*
Correspondence to: Jorge Gomez, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14623, USA, Tel: 716 845 1180. Fax: 716 845 7616. E-mail: Jorge.Gomez@RoswellPark.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim

We report a unique presentation of a late side effect associated with stereotactic body radiation therapy (SBRT) of the lung.

Summary

The case of a 65-year-old male who developed left-sided vocal cord paralysis after two courses of SBRT for squamous cell lung carcinoma is presented. The patient developed this late toxicity 15 months after his second treatment, which was to address a recurrence in the perihilar region of the left upper lobe.

Keywords

laryngeal nervesingle fractionstereotactic body radiation therapytoxicityvocal cord paralysis
Type
Case Study
Information
Journal of Radiotherapy in Practice , Volume 15 , Issue 4 , December 2016 , pp. 405 - 407
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Chang, J Y et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015; 16 (6): 630–637.CrossRefGoogle Scholar
2. Timmerman, R et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24 (30): 4833–4839.CrossRefGoogle Scholar
3. Forquer, J A et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 2009; 93 (3): 408–413.Google Scholar
4. Chaudhry, M R, Akhtar, S. Bilateral vocal cord paralysis following radiation therapy for nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 1995; 57 (1): 48–49.CrossRefGoogle ScholarPubMed
5. Johansson, S, Löfroth, P O, Denekamp, J. Left sided vocal cord paralysis: a newly recognized late complication of mediastinal irradiation. Radiother Oncol 2001; 58 (3): 287–294.Google Scholar
6. Senthi, S et al. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol 2013; 106 (3): 276–282.CrossRefGoogle ScholarPubMed
7. Videtic, G M et al. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys 2015; 93 (4): 757–764.Google Scholar
8. Hara, R et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 2006; 106 (6): 1347–1352.Google Scholar